Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDLipocine Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.49 | -$0.49 | -$0.49 |
| Q2 2026 | 1 | -$0.44 | -$0.44 | -$0.44 |
| Q3 2026 | 1 | -$0.45 | -$0.45 | -$0.45 |
| Q4 2026 | 1 | -$0.51 | -$0.51 | -$0.51 |
Lipocine Inc Earnings Date And Information
Lipocine Inc last posted its earnings results on Thursday, May 7th, 2026. The company reported $-0.54 earnings per share for the quarter, missing analysts' consensus estimates of $-0.51 by $0.03. The company had revenue of 119.40 K for the quarter and had revenue of 1.98 M for the year. Lipocine Inc has generated $-2 earnings per share over the last year ($-1.69 diluted earnings per share) and currently has a price-to-earnings ratio of -1.31. Lipocine Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Lipocine Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/07/2026 | Q1 2026 | -$0.51 | -$0.54 | -0.03 | $162.50 K | $119.40 K |
| 03/09/2026 | Q4 2025 | N/A | -$0.42 | N/A | $116.00 K | $1.15 M |
| 11/06/2025 | Q3 2025 | -$0.56 | -$0.59 | -0.03 | $238.00 K | $114.57 K |
| 08/05/2025 | Q2 2025 | -$0.41 | -$0.41 | 0 | $229.00 K | $622.85 K |
| 05/08/2025 | Q1 2025 | -$0.35 | -$0.35 | 0 | $352.00 K | $93.86 K |
| 03/13/2025 | Q4 2024 | -$0.40 | $0.33 | 0.73 | $2.61 M | $3.49 M |
| 11/07/2024 | Q3 2024 | -$0.48 | -$0.41 | 0.07 | $129.50 K | $0 |
| 08/08/2024 | Q2 2024 | -$0.78 | -$0.57 | 0.21 | $290.00 K | $89.57 K |
| 05/09/2024 | Q1 2024 | -$0.68 | $0.66 | 1.34 | N/A | $7.62 M |
| 03/07/2024 | Q4 2023 | -$0.53 | -$0.43 | 0.1 | N/A | $216.19 K |
| 11/08/2023 | Q3 2023 | -$0.57 | -$1.27 | -0.7 | N/A | $-3,121,996 |
| 08/10/2023 | Q2 2023 | -$0.64 | -$0.68 | -0.04 | N/A | $0 |
| 05/11/2023 | Q1 2023 | -$0.42 | -$0.76 | -0.34 | N/A | $54.99 K |
| 03/10/2023 | Q4 2022 | $0.03 | -$0.43 | -0.46 | N/A | $0 |
| 11/09/2022 | Q3 2022 | -$0.51 | -$0.52 | -0.01 | N/A | $0 |
| 08/08/2022 | Q2 2022 | -$0.68 | -$0.50 | 0.18 | N/A | $500.00 K |
| 05/09/2022 | Q1 2022 | -$0.34 | -$0.67 | -0.33 | N/A | $0 |
| 03/09/2022 | Q4 2021 | -$0.85 | $2.43 | 3.28 | N/A | $16.09 M |
| 11/10/2021 | Q3 2021 | -$0.85 | -$0.59 | 0.26 | N/A | $54.99 K |
| 08/05/2021 | Q2 2021 | -$0.85 | -$1.31 | -0.46 | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Lipocine Inc Earnings: FAQ's
The conference call for Lipocine Inc's latest earnings report can be listened to online.
The conference call transcript for Lipocine Inc's latest earnings report can be read online.
Lipocine Inc (:LPCN) has a recorded annual revenue of $1.98 M.
Lipocine Inc (:LPCN) has a recorded net income of $-9,627,505.Lipocine Inc has generated $-1.77 earnings per share over the last four quarters.
Lipocine Inc (:LPCN) has a price-to-earnings ratio of -1.31 and price/earnings-to-growth ratio is 0.02.